D-0785-2021 Class III Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0785-2021 was initiated by Teligent Pharma, Inc. on Jul 29, 2021 and is designated Class III. Reason for recall: Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing. The recall status is terminated (terminated Aug 15, 2024). Affected quantity: 114,456 tubes.

Recall details

Product Type
Drugs
Report Date
Sep 8, 2021
Initiation Date
Jul 29, 2021
Termination Date
Aug 15, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
114,456 tubes

Product description

Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-008-14.

Reason for recall

Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot #: 15378, Exp 3/2023; 14418 EXP 10/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0785-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0785-2021. Report a data issue: hello@regdatalab.com.